Showing 1091-1100 of 1211 results for "".
- Ocular Therapeutix to Present Preclinical and Clinical Data at ARVOhttps://modernod.com/news/ocular-therapeutix-to-present-preclinical-and-clinical-data-at-arvo/2479146/Ocular Therapeutix announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting. With the ARVO 2021 Annual Meeting being moved to a virtual format, video-recorded presentations are scheduled to become available online at ARVOLearn o
- Oxurion NV Presenting Scientific Data at ARVO 2021 Annual Meetinghttps://modernod.com/news/oxurion-nv-presenting-scientific-data-at-arvo-2021-annual-meeting/2479144/Oxurion NV is announcing the presentation of novel scientific data at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting which is held on May 1-7, 2021. The details of the presentation are as follows: Title: The Mouse Sodium Iodate Mo
- CooperVision Reveals New Ocular Research at ARVO 2021 Virtual Meetinghttps://modernod.com/news/coopervision-reveals-new-ocular-research-at-arvo-2021-virtual-meeting/2479142/CooperVision will present five new research posters as part of the Association for Research in Vision and Ophthalmology (ARVO) 2021 Virtual Meeting, May 1-7. They include original models for evaluating myopia management treatment efficacy as well as emergent physiological factors that affect cont
- Bausch + Lomb Will Present New Scientific Data And Analyses On Products And Pipeline Programs During ARVO 2021https://modernod.com/news/bausch-lomb-will-present-new-scientific-data-and-analyses-on-products-and-pipeline-programs-during-arvo-2021/2479139/Bausch + Lomb announced the presentation of new scientific data and clinical analyses, including one podium presentation and 11 poster presentations, during the virtual Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place from Ma
- Allegro Ophthalmics Announces New Scientific Data to Be Presented During the 2021 ARVO Annual Meetinghttps://modernod.com/news/allegro-ophthalmics-announces-new-scientific-data-to-be-presented-during-the-2021-arvo-annual-meeting/2479123/Allegro Ophthalmics announced that four scientific posters involving risuteganib, the company’s lead investigational compound in retina, will be presented during the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, being held virtually May 1-7, 2021. “It’s e
- Allergan to Share New Data Highlighting Latest Advancements in Eye Care at ARVO 2021https://modernod.com/news/allergan-to-share-new-data-highlighting-latest-advancements-in-eye-care-at-arvo-2021/2479116/Allergan announced that it will present new data, including real-world evidence, and patient-reported outcomes (PROs) for products across its eye care portfolio and pipeline at the ARVO (Association for Research in Vision and Ophthalmology) 2021 Annual Virtual Meeting (May
- ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at ARVO 2021https://modernod.com/news/proqr-announces-virtual-presentation-of-phase-1-2-sepofarsen-extension-trial-data-at-arvo-2021/2479108/ProQR Therapeutics announced a virtual oral presentation of data from the company’s phase 1/2 InSight extension trial of sepofarsen and live Q&A session at the Association for Research in Vision and Ophthalmology (ARVO) held May 1-7, 2021. This is an encore presentation of the In
- Ocuphire’s APX3330 for Retinal Diseases to be Presented at ARVO 2021https://modernod.com/news/ocuphires-apx3330-for-retinal-diseases-to-be-presented-at-arvo-2021/2479102/Ocuphire Pharma announced that data from preclinical studies and pharmacokinetic modeling of the company’s proprietary APX3330 drug candidate will be presented on Sunday, May 2, 2021 during the Association for Research in Vision and Ophthalmology (ARVO) virtual Annual Meeting, May 1-7, 2021.
- Neurophth Announces IND Approval in China for Leber Hereditary Optic Neuropathy Gene Therapyhttps://modernod.com/news/neurophth-announces-ind-approval-in-china-for-leber-hereditary-optic-neuropathy-gene-therapy/2479055/Neurophth Biotechnology announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved the company’s investigational new drug (IND) application of NR082 (recombinant adeno-associated virus serotype 2 carrying ND4 gene; rAAV2-ND
- New Educational Resource On Importance of Eye Protection in Sports/Recreational Activititeshttps://modernod.com/news/new-educational-resource-on-importance-of-eye-protection-in-sports-recreational-activitites/2479046/The International Sports Vision Association (ISVA) and Zyloware Eyewear announced the launch of Protect. Prevent. Play., a new educational resource designed to help eye care professionals educate parents, coaches, teachers, athletic trainers and athletes of all ages and skill levels abou